• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Delayed Hemolytic Transfusion Reactions are Under Diagnosed in Patients with Sickle Cell Disease

May 1, 2019

Red blood cell transfusions are often used to treat patients with sickle cell disease (SCD), and these patients are at risk for developing alloantibodies that can lead to delayed hemolytic transfusion reactions (DHTRs). The diagnosis of DHTR is often difficult because alloantibodies can be undetectable and symptoms can mimic vaso-occlusive events. In order to gain a better understanding of the incidence and severity of DHTRs, researchers retrospectively analyzed data from 624 patients with SCD who received at least one transfusion over 14 years. New alloantibodies were identified in 124 of 624 patients (19.9%) who received over 47,000 RBC units. A total of 239 alloantibodies were identified; Rh alloantibodies were the most frequent (61%) despite D, C, E, and K1-matching. Of the 178/239 alloantibodies from 89 patients eligible to be evaluated, 54 (30.3%) were associated with laboratory values indicative of DHTR, though less than half of these were clinically diagnosed. DHTRs are common in patients with SCD and further research is needed to prevent, diagnose and treat these transfusion reactions.

Reference:

Coleman S, Westhoff CM, Friedman DF, and Chou ST. Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.

Filed Under

  • Adverse Events (non-infectious)
  • News
  • RBC Transfusion

Recommended

  • Decreases in U.S. Blood Donors Despite Increases in Eligible Donors

  • Tranexamic Acid Reduces Risk of Death in Patients with Traumatic Brain Injury

  • Blood from Younger Donors Does Not Affect Patient Survival after Transfusion

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley